Invyncible Review
Best for: Florida-region buyers seeking a corporate-parent-disclosed telehealth GLP-1 platform with a verifiable LegitScript seal and clear accountability address, who are willing to sign up to see specific pricing, drug forms, and pharmacy partner details.
Invyncible (invyncible.com) is a Florida-based telehealth platform offering Semaglutide and Tirzepatide programs for weight management. Corporate parent EXPLICITLY disclosed in footer: 'Nationwide Telemedicine, LLC' (clear LLC designation — uncommon transparency vs DTC competitors that hide ownership). Corporate physical address verbatim: '204 37th Ave N., #337 St. Petersburg, FL 33704.' Brand tagline: 'Medical Wellness and Weight Management—from home.' Trust framing: 'No long-term commitment' + 'licensed providers' + 'licensed physicians' (network details not specified). LegitScript verification seal displayed on homepage (specific ID number not publicly visible). Pricing tiers, full states-served list, named pharmacy partner, 503A vs 503B compounding designation, FDA compounded-medication disclaimer text, named medical director, and detailed refund policy are NOT publicly disclosed (subpaths /pricing, /semaglutide, /programs all return 404 — site is JS-routed SPA with most content gated behind sign-up flow). Live-verified 2026-05-19.
Medium confidence · Last verified 2026-05-19 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Invyncible is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Invyncible prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
✓ Pros
- •Corporate parent EXPLICITLY disclosed (Nationwide Telemedicine, LLC) — better than the majority of DTC competitors that hide ownership behind trade names
- •Physical corporate address published (204 37th Ave N., #337 St. Petersburg, FL 33704) — accountability signal
- •LegitScript verification seal displayed — basic certification signal
- •No long-term commitment framing reduces sign-up friction
- •Both semaglutide and tirzepatide programs offered
✗ Cons
- •Pricing tiers NOT disclosed on the public homepage — fully gated behind sign-up flow
- •Specific drug forms (compounded vs brand-name; injection vs oral) NOT disclosed on homepage
- •503A vs 503B compounding designation NOT specified
- •Pharmacy partner NOT named
- •LegitScript ID NUMBER not publicly visible (only the seal)
- •States-served list NOT disclosed publicly
- •Named medical director / clinical leadership NOT disclosed
- •FDA compounded-medication disclaimer NOT published on the homepage
- •Site is JavaScript-rendered SPA — subpaths /pricing, /semaglutide, /programs all return 404 via standard URL guessing; most content gated behind /get-started flow
- •Governing law / arbitration venue NOT disclosed publicly
- •Refund policy details NOT disclosed beyond 'no long-term commitment' framing
Ready to start with Invyncible?
See current pricing and start your free consultation.
Sources & methodology
Our Invyncible review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
Alternatives to Invyncible
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Invyncible?
See current pricing and start your free consultation.